Old Web
English
Sign In
Acemap
>
authorDetail
>
E. Moore
E. Moore
Cornell University
Medicine
Oncology
Internal medicine
Pathology
Lung cancer
6
Papers
312
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus.
2007
Clinical Cancer Research
Gregory J. Riely
Mark G. Kris
Binsheng Zhao
Tim Akhurst
Daniel T. Milton
E. Moore
Leslie Tyson
William Pao
Naiyer A. Rizvi
Lawrence H. Schwartz
Vincent A. Miller
Show All
Source
Cite
Save
Citations (268)
A phase II study to determine if sensory neuropathy of nab-paclitaxel can be reduced by prolonging infusion in patients with non-small cell lung cancer (NSCLC)
2007
Journal of Clinical Oncology
Leonard P. James
M G Kris
Robert T. Heelan
Kenneth K. Ng
G. H. Chia
Jorge Gomez
Lee M. Krug
E. Moore
Michael J. Hawkins
N.A. Rizvi
Show All
Source
Cite
Save
Citations (2)
Combined inhibition of mTOR and EGFR with everolimus (RAD001) and gefitinib in patients with non-small cell lung cancer who have smoked cigarettes: A phase II trial
2007
Journal of Clinical Oncology
M. G. Kris
G. J. Riely
Christopher G. Azzoli
Robert T. Heelan
Lee M. Krug
William Pao
Daniel T. Milton
E. Moore
N. A. Rizvi
Vincent A. Miller
Show All
Source
Cite
Save
Citations (23)
1